Oral Cholera Vaccine Market
Oral Cholera Vaccine Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Oral Cholera Vaccine Market Size and Growth
The Oral Cholera Vaccine market is experiencing significant growth, driven by rising incidences of cholera and increasing vaccination programs. The market size is projected to reach approximately USD 300 million by 2025, with key drivers including governmental initiatives and heightened awareness of vaccine efficacy in endemic regions. Competitive dynamics shape market strategies.
Companies Covered
(Covid 19 Impact Covered)
◍ PaxVax
◍ Sanofi
◍ Valneva
◍ EuBiologics
◍ United Biotech
◍ Vabiotech
◍ PaxVax
The Oral Cholera Vaccine market features key players like PaxVax, Sanofi, and Valneva, focusing on R&D and market expansion. These companies enhance vaccine accessibility and awareness, driving growth. Sales figures include: PaxVax: ~$100 million, Sanofi: ~$1.3 billion (Global vaccine revenue), Valneva: ~$20 million, boosting market confidence and adoption. Request Sample Report
Market Segmentation
By Application
Preventive Campaigns
Outbreak Response
Request Sample Report
By Product
Euvichol-Plus
DUKORAL
Shanchol
Others
Market Growth
Request Sample Report
$ X Billion USD
